Hepatitis C team care for people in supportive housing
Part of Digestive system, Infections clinical trials.
This study tests a team-based approach — a pharmacist, doctor, and patient navigator working together — to help people living in permanent supportive housing get hepatitis C care. If you have hepatitis C and live in DESC housing, the study will check how well this team helps you through treatment over 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You live in a DESC permanent supportive housing building
- You have tested positive for hepatitis C (antibody or viral load test)
- You are not already taking hepatitis C medication
- You can give permission for researchers to access your pharmacy and medical records
- You are not planning to leave the Seattle area within the next 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether having your injecting partner help support you after hepatitis C treatment keeps you more engaged with healthcare. Researchers will check in with you and your partner a few months after your treatment ends to see if extra support helps.
This study tests hepatitis C virus (HCV) treatment using medications called sofosbuvir and velpatasvir, with the goal of curing the infection. If you've been treated before and the virus came back, you may be eligible for retreatment with additional medication.
This study offers a once-daily pill (Epclusa) to treat hepatitis C for people in jail who have never taken HCV medicine before. The goal is to see if starting treatment while incarcerated and continuing after release can cure the infection.
This study tests whether people who come to the emergency department can get tested for hepatitis C and start treatment right away, all in one visit. It aims to make treatment easier and faster for those who test positive.
This study tests a telehealth program to help people who inject drugs in rural Southern areas prevent HIV and get care for hepatitis C. It's designed to be supportive and help you build strength to stay healthy.
This study tests whether persuasive, health-message coaching can help people reduce risk for HIV or hepatitis C (HCV). You may be eligible if you’re not infected with HIV or HCV and haven’t been tested for either in the last year.
Hear when a new HEPATITIS C (HCV) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.